Ann Clin Microbiol.  2022 Sep;25(3):85-90. 10.5145/ACM.2022.25.3.3.

Antimicrobial Susceptibility Patterns and Clinical Characteristics of Corynebacterium striatum Cases from 2018 to 2021

Affiliations
  • 1Department of Laboratory Medicine, Hanyang University College of Medicine, Seoul, Korea

Abstract

Background
Corynebacterium striatum is part of the normal flora of the skin, oral cavity, and intestine. However, it can be a pathogen causing endocarditis, pneumonia, arthritis, and meningitis occasionally. We evaluated the clinical features and antimicrobial susceptibility pattern of C. striatum cases.
Methods
Patients infected with C. striatum, who consulted infectious disease physicians and were admitted to Hanyang University hospital between January 2018 and January 2021, were enrolled for an antimicrobial susceptibility test (AST). We reviewed medical records of selected patients for information on diagnosis, specimen types, and antibiotics used before and after AST. AST was performed using E-test and interpreted according to the Clinical and Laboratory Standards Institute M45 guidelines.
Results
A total of 23 cases were evaluated, and average age of patients was 58.5 years. Ten cases were diagnosed sepsis. Eight cases were complicated with cancer, and five cases had wound infections. Four cases were treated with vancomycin prior to AST; in 13 cases, antibiotics were switched to vancomycin after AST. Resistance rates were highest for ciprofloxacin (93.3%), which was followed by cefotaxime (92.3%), penicillin G (87.0%), erythromycin (87.0%), trimethoprim/sulfamethoxazole (78.3%), and meropenem (76.5%).
Conclusion
The patients infected by C. striatum were old and immunosuppressed, while many had cancer. Since C. striatum shows resistance to most drugs except vancomycin, we should consider conducting AST prior to antibiotic treatment.

Keyword

Antimicrobial susceptibility pattern; Corynebacterium striatum; Multi-drug resistance
Full Text Links
  • ACM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr